Detection of active human cytomegalovirus in patients with multiple myeloma

被引:0
|
作者
Al-Douri, Aya Atheer [1 ]
Abdullah, Shatha Farouk [2 ]
Al-Mothaffar, Ali Mohammed Jawad [3 ]
机构
[1] Univ Baghdad, Baghdad Teaching Hosp Labs, Baghdad Med City, Baghdad, Iraq
[2] Univ Baghdad, Coll Med, Dept Microbiol, Baghdad, Iraq
[3] Univ Baghdad, Coll Med, Dept Med, Baghdad, Iraq
关键词
Human cytomegalovirus; multiple myeloma; real-time polymerase chain reaction; STEM-CELL TRANSPLANTATION; HIGH-DOSE THERAPY; EARLY DEATH; INFECTIONS; REACTIVATION; TRANSFUSION; MANAGEMENT; DIAGNOSIS; ERA;
D O I
10.4103/ijh.ijh_5_24
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Human cytomegalovirus (HCMV) infection is ubiquitous and successfully reactivated in patients with immune dysfunction as in patient with multiple myeloma (MM), causing a wide range of life-threatening diseases. Early detection of HCMV and significant advances in MM management has amended patient outcomes and prolonged survival rates.OBJECTIVES: The aim of the study was to estimate the frequency of active HCMV in MM patients.MATERIALS AND METHODS: This is a case-control study involved 50 MM patients attending Hematology Center, Baghdad Teaching Hospital; 25 of them were newly diagnosed and 25 on treatment compared to 50 of apparently healthy control. HCMV-viral load was measured using a real-time polymerase chain reaction (RT-PCR).RESULTS: Active HCMV was detected in 8 patients out of 50 (16%); 6/25 (24%) in newly diagnosed and 2/25 (8%) on treatment and had autologous bone marrow transplant with mean +/- standard deviation of 910 x 1010 +/- 210 x 1010, and 32,000 x 1010 +/- 1500 x 1010 IU/mL, respectively. HCMV viremia is equally detected in both remission and relapsed cases.CONCLUSION: RT-PCR detected a significant number of MM patients infected by cytomegalovirus compared to healthy individuals. Further studies are needed to verify if this finding has a relation to etiology or disease progression.
引用
收藏
页码:101 / 105
页数:5
相关论文
共 50 条
  • [1] Cytomegalovirus reactivation in patients with multiple myeloma
    Hasegawa, Tetsuo
    Aisa, Yoshinobu
    Shimazaki, Kengo
    Ito, Chisako
    Nakazato, Tomonori
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 96 (01) : 78 - 82
  • [2] Detection of human cytomegalovirus DNA in Iranian patients with multiple sclerosis
    Sanadgol, N.
    Ramroodi, N.
    Komijani, M.
    Rezaei, M.
    JOURNAL OF CLINICAL VIROLOGY, 2009, 46 : S57 - S57
  • [3] Cytomegalovirus Reactivation during Elotuzumab Therapy in Patients with Multiple Myeloma
    Kikuchi, Taku
    Tsukada, Nobuhiro
    Kunisada, Kodai
    Nomura-Yogo, Moe
    Oda, Yuki
    Sato, Kota
    Takei, Tomomi
    Ogura, Mizuki
    Abe, Yu
    Suzuki, Kenshi
    Ishida, Tadao
    ACTA HAEMATOLOGICA, 2024,
  • [4] CYTOMEGALOVIRUS DNA DETECTION IN SERA FROM PATIENTS WITH ACTIVE CYTOMEGALOVIRUS INFECTIONS
    BRYTTING, M
    XU, WM
    WAHREN, B
    SUNDQVIST, VA
    JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (08) : 1937 - 1941
  • [5] Pattern of the Epitope-Specific IgG/IgM Response against Human Cytomegalovirus in Patients with Multiple Myeloma
    Bogner, Elke
    Pecher, Gabriele
    CLINICAL AND VACCINE IMMUNOLOGY, 2013, 20 (08) : 1298 - 1304
  • [6] Detection of early relapse in multiple myeloma patients
    Ruzickova, Tereza
    Vlachova, Monika
    Pecinka, Lukas
    Brychtova, Monika
    Vecera, Marek
    Radova, Lenka
    Sevcikova, Simona
    Jarosova, Marie
    Havel, Josef
    Pour, Ludek
    Sevcikova, Sabina
    CELL DIVISION, 2025, 20 (01)
  • [7] Bone marrow angiogenesis in patients with active multiple myeloma
    Vacca, A
    Ribatti, D
    Roccaro, AM
    Frigeri, A
    Dammacco, F
    SEMINARS IN ONCOLOGY, 2001, 28 (06) : 543 - 550
  • [8] Cytomegalovirus reactivation in patients with multiple myeloma administered daratumumab-combination regimens
    Rikako Tabata
    Nobue Sato
    Nobuhiko Yamauchi
    Yong-Mei Guo
    Hirotaka Nakamura
    Akihito Nagata
    Chi Song-Gi
    Yosuke Minami
    Junichiro Yuda
    Annals of Hematology, 2022, 101 : 465 - 467
  • [9] Cytomegalovirus infection during daratumumab therapy in patients with newly diagnosed multiple myeloma
    Kikuchi, Taku
    Tsukada, Nobuhiro
    Kunisada, Kodai
    Nomura-Yogo, Moe
    Oda, Yuki
    Sato, Kota
    Takei, Tomomi
    Ogura, Mizuki
    Abe, Yu
    Suzuki, Kenshi
    Ishida, Tadao
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 120 (01) : 91 - 95
  • [10] Cytomegalovirus reactivation in patients with multiple myeloma administered daratumumab-combination regimens
    Tabata, Rikako
    Sato, Nobue
    Yamauchi, Nobuhiko
    Guo, Yong-Mei
    Nakamura, Hirotaka
    Nagata, Akihito
    Chi, Song-Gi
    Minami, Yosuke
    Yuda, Junichiro
    ANNALS OF HEMATOLOGY, 2022, 101 (02) : 465 - 467